Kuros Biosciences CSBTF Stock
Kuros Biosciences Price Chart
Kuros Biosciences CSBTF Financial and Trading Overview
| Kuros Biosciences stock price | 24 USD |
| Previous Close | 24 USD |
| Open | 24 USD |
| Bid | 22.13 USD x 10000 |
| Ask | 25.64 USD x 10000 |
| Day's Range | 24 - 24 USD |
| 52 Week Range | 22 - 39.73 USD |
| Volume | 1K USD |
| Avg. Volume | 60 USD |
| Market Cap | 954.16M USD |
| Beta (5Y Monthly) | 0.759 |
| PE Ratio (TTM) | 109.09091 |
| EPS (TTM) | 0.22 USD |
| Forward Dividend & Yield | N/A (0%) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
CSBTF Valuation Measures
| Enterprise Value | 961.42M USD |
| Trailing P/E | 109.09091 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 5.4544663 |
| Price/Book (mrq) | 10.767159 |
| Enterprise Value/Revenue | 5.496 |
| Enterprise Value/EBITDA | 73.47 |
Trading Information
Kuros Biosciences Stock Price History
| Beta (5Y Monthly) | 0.759 |
| 52-Week Change | -39.59% |
| S&P500 52-Week Change | 12.83% |
| 52 Week High | 39.73 USD |
| 52 Week Low | 22 USD |
| 50-Day Moving Average | 24.87 USD |
| 200-Day Moving Average | 27.44 USD |
CSBTF Share Statistics
| Avg. Volume (3 month) | 60 USD |
| Avg. Daily Volume (10-Days) | 15 USD |
| Shares Outstanding | 39.76M |
| Float | 30.57M |
| Short Ratio | N/A |
| % Held by Insiders | 34.28% |
| % Held by Institutions | 23.65% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:100 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 5.12% |
| Operating Margin (ttm) | 5.60% |
| Gross Margin | 88.23% |
| EBITDA Margin | 7.48% |
Management Effectiveness
| Return on Assets (ttm) | 5.12% |
| Return on Equity (ttm) | 10.73% |
Income Statement
| Revenue (ttm) | 174.93M USD |
| Revenue Per Share (ttm) | 4.56 USD |
| Quarterly Revenue Growth (yoy) | 45.50% |
| Gross Profit (ttm) | 154.34M USD |
| EBITDA | 13.09M USD |
| Net Income Avi to Common (ttm) | 8.9M USD |
| Diluted EPS (ttm) | 0.22 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 9.73M USD |
| Total Cash Per Share (mrq) | 0.24 USD |
| Total Debt (mrq) | 10.07M USD |
| Total Debt/Equity (mrq) | 11.28 USD |
| Current Ratio (mrq) | 1.871 |
| Book Value Per Share (mrq) | 2.229 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -621000 USD |
| Levered Free Cash Flow (ttm) | -9361000 USD |
Profile of Kuros Biosciences
| Country | United States |
| State | N/A |
| City | Schlieren |
| Address | Wagistrasse 25 |
| ZIP | 8952 |
| Phone | 41 44 733 4747 |
| Website | https://www.kurosbio.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 213 |
Kuros Biosciences AG engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally. It operates through two segments, Medical Devices and Legacy Portfolio. The company provides MagnetOs Granules, an advanced bone graft based on the submicron needle-shaped NeedleGrip surface technology; MagnetOs Putty, a mold uses to fill bony voids for intervertebral disc space or posterolateral spine; and Attrax, a biphasic calcium phosphate bone grafts that mimic the porous and trabecular structure of cancellous bone, as well as checkmate licensing. The company was incorporated in 2016 and is headquartered in Schlieren, Switzerland.
Q&A For Kuros Biosciences Stock
What is a current CSBTF stock price?
Kuros Biosciences CSBTF stock price today per share is 24 USD.
How to purchase Kuros Biosciences stock?
You can buy CSBTF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Kuros Biosciences?
The stock symbol or ticker of Kuros Biosciences is CSBTF.
Which industry does the Kuros Biosciences company belong to?
The Kuros Biosciences industry is Medical Devices.
How many shares does Kuros Biosciences have in circulation?
The max supply of Kuros Biosciences shares is 39.76M.
What is Kuros Biosciences Price to Earnings Ratio (PE Ratio)?
Kuros Biosciences PE Ratio is 109.09091000 now.
What was Kuros Biosciences earnings per share over the trailing 12 months (TTM)?
Kuros Biosciences EPS is 0.22 USD over the trailing 12 months.
Which sector does the Kuros Biosciences company belong to?
The Kuros Biosciences sector is Healthcare.
